Preeclampsia: Short-term and Long-term Implications

Obstetrics and Gynecology Clinics of North America

Volumn 42, Issue 2, 2015, Pages 299-313

  Pauli, Jaimey M ^a   Repke, John T ^a  

^a PENN STATE MILTON S HERSHEY MEDICAL CENTER   (United States)

Author keywords

Cardiovascular risk; Hypertension; Preeclampsia; Pregnancy; Prenatal screening

Indexed keywords

ACETYLSALICYLIC ACID; HYDRALAZINE; LABETALOL; METHYLDOPA; NIFEDIPINE; THIAZIDE DIURETIC AGENT; ANTIHYPERTENSIVE AGENT;

CARDIOVASCULAR RISK; CLINICAL FEATURE; DISEASE SEVERITY; FETUS MORTALITY; GESTATIONAL AGE; HIGH RISK PATIENT; HUMAN; LOW DRUG DOSE; MATERNAL MORBIDITY; MATERNAL MORTALITY; MULTIPLE ORGAN FAILURE; PATHOPHYSIOLOGY; PERINATAL MORBIDITY; PLACENTAL DELIVERY; PREECLAMPSIA; PRIORITY JOURNAL; PROPHYLAXIS; PROTEINURIA; PUERPERIUM; RECURRENCE RISK; REVIEW; RISK ASSESSMENT; RISK REDUCTION; SCREENING TEST; ADULT; CLINICAL PRACTICE; DELIVERY; DIRECTIVE COUNSELING; FEMALE; HIGH RISK PREGNANCY; NEWBORN; PHYSIOLOGIC MONITORING; PRACTICE GUIDELINE; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY COMPLICATIONS, CARDIOVASCULAR; PREGNANCY OUTCOME; PRENATAL CARE; PROCEDURES; PROGNOSIS; RISK FACTOR;

ADULT; ANTIHYPERTENSIVE AGENTS; DELIVERY, OBSTETRIC; DIRECTIVE COUNSELING; FEMALE; HUMANS; INFANT, NEWBORN; MONITORING, PHYSIOLOGIC; PRACTICE GUIDELINES AS TOPIC; PRACTICE PATTERNS, PHYSICIANS'; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY COMPLICATIONS, CARDIOVASCULAR; PREGNANCY OUTCOME; PREGNANCY, HIGH-RISK; PRENATAL CARE; PROGNOSIS; RISK FACTORS;

EID: 84931449837     PISSN: 08898545     EISSN: 15580474     Source Type: Journal    
DOI: 10.1016/j.ogc.2015.01.007     Document Type: Review

References (40)

1. Creasy R.K. Creasy and Resnik's Maternal-Fetal Medicine: Principles and Practice: Expert Consult Premium Edition. 7th edition 2013, Elsevier Saunders, Philadelphia.
2. Ananth C.V., Keyes K.M., Wapner R.J. Pre-eclampsia rates in the United States, 1980-2010: age-period-cohort analysis. BMJ 2013, 347:f6564.
3. Wallis A.B., Saftlas A.F., Hsia J. Secular trends in the rates of preeclampsia, eclampsia, and gestational hypertension, United States, 1987-2004. Am J Hypertens 2008, 21:521-526.
4. American College of Obstetricians and Gynecologists, Task Force on Hypertension in Pregnancy Hypertension in pregnancy. Report of the American College of Obstetricians and Gynecologists' Task Force on Hypertension in Pregnancy. Obstet Gynecol 2013, 122(5):1122-1131.
5. Bell M.J. Ahistorical view of preeclampsia-eclampsia. JObstet Gynecol Neonatal Nurs 2010, 39:510-518.
6. Velauthar L., Plana M.N., Kalidindi M., et al. First-trimester uterine artery Doppler and adverse pregnancy outcome: a meta-analysis involving 55 974 women. Ultrasound Obstet Gynecol 2014, 43:500-507.
7. Crispi F., Llurba E., Domínguez C., et al. Predictive value of angiogenic factors and uterine artery Doppler for early- versus late-onset pre-eclampsia and intrauterine growth restriction. Ultrasound Obstet Gynecol 2008, 31:303-309.
8. von Dadelszen P., Menzies J.M., Payne B., et al. Predicting adverse outcomes in women with severe pre-eclampsia. Semin Perinatol 2009, 33:152-157.
9. Duckitt K., Harrington D. Risk factors for pre-eclampsia at antenatal booking: systematic review of controlled studies. BMJ 2005, 330(7491):565.
10. Barton J., Sibai B. Prediction and prevention of recurrent preeclampsia. Obstet Gynecol 2008, 112(2):359-372.
11. O'Brien T.E., Ray J.G., Chan W.S. Maternal body mass index and the risk of preeclampsia: a systematic overview. Epidemiology 2003, 14(3):368.
12. Poon L.C., Kametas N.A., Chelemen T., et al. Maternal risk factors for hypertensive disorders in pregnancy: a multivariate approach. JHum Hypertens 2010, 24(2):104-110.
13. Meekins J.W., Ijnenbor R.P., Anssen M.H., et al. Astudy of placental bed spiral arteries and trophoblast invasion in normal and severe pre-eclamptic pregnancies. BJOG 1994, 101:669-674.
14. Ayala A.R., Rodríguez de la Fuente F., Díaz Loya F., et al. Evidence that a toxemia-related organism (Hydatoxi lualba) is an artifact. Obstet Gynecol 1986, 67(1):47-50.
15. Widmer M., Villar J., Benigni A., et al. Mapping the theories of preeclampsia and the role of angiogenic factors: a systemic review. Obstet Gynecol 2007, 109:168-180.
16. McKeeman G.C., Ardill J.E., Caldwell C.M., et al. Soluble vascular endothelial growth factor receptor-1 (sFlt-1) is increased throughout gestation in patients who have preeclampsia develop. Am J Obstet Gynecol 2004, 191:1240-1246.
17. North R.A., McCowan L.M., Dekker G.A. Clinical risk prediction for pre-eclampsia in nulliparous women: development of model in international prospective cohort. BMJ 2011, 342:d1875.
18. Cnossen J.S., Morris R.K., ter Riet G., et al. Use of uterine artery Doppler ultrasonography to predict pre-eclampsia and intrauterine growth restriction: a systematic review and bivariable meta-analysis. CMAJ 2008, 178(6):701-711.
19. Audibert F., Boucoiran I., An N., et al. Screening for preeclampsia using first-trimester serum markers and uterine artery Doppler in nulliparous women. Am J Obstet Gynecol 2010, 203:383.e1-383.e8.
20. Myatt L., Clifton R.G., Roberts J.M., et al. First-trimester prediction of preeclampsia in nulliparous women at low risk. Obstet Gynecol 2012, 119:1234-1242.
21. Goetzinger K.R., Odibo A.O. Screening for abnormal placentation and adverse pregnancy outcomes with maternal serum biomarkers in the second trimester. Prenat Diagn 2014, 34:635-641.
22. Martin A., Krishna I., Martina B., et al. Can the quantity of cell-free fetal DNA predict preeclampsia: a systematic review. Prenat Diagn 2014, 34:685-691.
23. Sibai B.M., Lindheimer M., Hauth J., et al. Risk factors for preeclampsia, abruption placentae, and adverse neonatal outcomes among women with chronic hypertension. National Institute of Child Health and Human Development network of maternal-fetal medicine units. NEngl J Med 1998, 339:667-671.
24. Ferrer R.L., Sibai B.M., Mulrow C.D., et al. Management of mild chronic hypertension during pregnancy: a review. Obstet Gynecol 2000, 96:849-860.
25. Sibai B.M. Evaluation and management of severe preeclampsia before 34 weeks' gestation. Am J Obstet Gynecol 2011, 205(3):191-198.
26. Sibai B.M. Magnesium sulfate prophylaxis in preeclampsia: lessons learned from recent trials. Am J Obstet Gynecol 2004, 190:1520-1526.
27. Cahill A.G., Macones G.A., Odibo A.O., et al. Magnesium for seizure prophylaxis in patients with mild preeclampsia. Obstet Gynecol 2007, 110:601-607.
28. Sibai B.M. Etiology and management of postpartum hypertension-preeclampsia. Am J Obstet Gynecol 2012, 206(6):470-475.
29. Bujold E., Roberge S., Lacasse Y., et al. Prevention of preeclampsia and intrauterine growth restriction with aspirin started in early pregnancy: a meta-analysis. Am J Obstet Gynecol 2010, 116(2):402-414.
30. Wallenburg H.C., Dekker G.A., Makovitz J.W., et al. Low-dose aspirin prevents pregnancy induced hypertension and pre-eclampsia in angiotensin-sensitive primigravidae. Lancet 1986, 1:1-3.
31. Schiff E., Peleg E., Goldenberg M., et al. The use of aspirin to prevent pregnancy-induced hypertension and lower the ratio of thromboxane A2 to prostacyclin in relatively high risk pregnancies. NEngl J Med 1989, 321:351-356.
32. Trivedi N.A. Ameta-analysis of low-dose aspirin for prevention of preeclampsia. JPostgrad Med 2011, 57:91-95.
33. Coomarasamy A., Honest H., Papaioannou S., et al. Aspirin for prevention of preeclampsia in women with historical risk factors: a systematic review. Obstet Gynecol 2003, 1010(6):1319-1332.
34. Ahmed R., Dunford J., Mehran R., et al. Pre-eclampsia and future cardiovascular risk among women: a review. JAm Coll Cardiol 2014, 63:1815-1822.
35. Bellamy L., Casas J.P., Hingorani A.D., et al. Pre-eclampsia and risk of cardiovascular disease and cancer in later life: systematic review and meta-analysis. BMJ 2007, 335(7627):974.
36. Aukes A., De Groot J., Wiegman M., et al. Long-term cerebral imaging after pre-eclampsia. BJOG 2012, 119:1117-1122.
37. Sibai B.M., Mercer B., Sarinoglu C. Severe preeclampsia in the second trimester: recurrence risk and long-term prognosis. Am J Obstet Gynecol 1991, 165(5 Pt 1):1408.
38. van Rijn B.B., Hoeks L.B., Bots M.L., et al. Outcomes of subsequent pregnancy after first pregnancy with early-onset preeclampsia. Am J Obstet Gynecol 2006, 195(3):723.
39. Bramham K., Briley A.L., Seed P., et al. Adverse maternal and perinatal outcomes in women with previous preeclampsia: a prospective study. Am J Obstet Gynecol 2011, 204(6):512.e1.
40. Mostello D., Kallogjeri D., Tungsiripat R., et al. Recurrence of preeclampsia: effects of gestational age at delivery of the first pregnancy, body mass index, paternity, and interval between births. Am J Obstet Gynecol 2008, 199(1):55.e1.